Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
CTRL Therapeutics Launches with $10M Seed Financing to Advance Next-Generation Cell Therapy Platform for the Treatment of Solid Tumors
CTRL Therapeutics, a biotechnology company developing a next-generation cell therapy platform for solid tumors, has […]
Ultima Genomics and Genome Insight Collaborate to Bring Affordable Whole Genome Sequencing to Cancer Patients
Ultima Genomics and Genome Insight have signed an agreement to collaborate to bring affordable whole […]
Consumer Longevity Company Tally Health™ Announces $10M Seed Round Led by Forerunner Ventures with Celebrity Participation
Tally Health, a revolutionary consumer biotechnology company created to change the way we age, announces […]
Canaan Closes $850 Million to Continue 35-Year History of Building and Supporting Transformational Technology and Healthcare Companies
Canaan today announced $850 million in new capital to continue the firm’s 35-year history of […]
Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio
Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge technology innovation and […]
Ochre Bio Strengthens Leadership Team and Board of Directors with Liver Disease Translational Expertise
Ochre Bio, an innovator in chronic liver disease medicine development, is pleased to announce the […]
Abivax Appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
Abivax, a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune […]
Felix Raises $18M CDN to Scale On-Demand Treatment for Everyday Health
Felix, Canada’s leading provider of on-demand treatment for everyday health, announces it has completed its […]
SamaCare Welcomes Komodo Health CEO Arif Nathoo to Board of Directors
SamaCare, a prior authorization platform for physician-administered medications, is excited to announce the addition of […]
Boston Scientific Closes Acquisition of Apollo Endosurgery
Boston Scientific today announced the close of its acquisition of Apollo Endosurgery, a publicly traded […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more